Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PBH Prestige Consumer Healthcare Inc
- Stocks
- Healthcare
- NYSE: PBH
Price (delayed)
$84.79
Market cap
$4.19B
P/E Ratio
19.63
Dividend/share
N/A
EPS
$4.32
Enterprise value
$5.14B
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio
Highlights
The quick ratio has increased by 43% YoY and by 29% from the previous quarter
The equity has grown by 11% YoY and by 2.6% from the previous quarter
PBH's P/E is 32% above its 5-year quarterly average of 14.9 and 9% above its last 4 quarters average of 18.0
Key stats
What are the main financial stats of PBH
Market
Valuations
Earnings
Shares outstanding
49.41M
Market cap
$4.19B
Enterprise value
$5.14B
Price to earnings (P/E)
19.63
Price to book (P/B)
2.29
Price to sales (P/S)
3.7
EV/EBIT
15.48
EV/EBITDA
13.91
EV/Sales
4.51
Revenue
$1.14B
Gross profit
$634.46M
Operating income
$336.78M
Net income
$214.61M
EBIT
$331.82M
EBITDA
$369.24M
Free cash flow
$243.29M
Per share
Balance sheet
Liquidity
EPS
$4.32
EPS diluted
$4.29
Free cash flow per share
$4.9
Book value per share
$37.04
Revenue per share
$22.89
TBVPS
$11.66
Total assets
$3.4B
Total liabilities
$1.57B
Debt
$1.04B
Equity
$1.83B
Working capital
$341.71M
Debt to equity
0.57
Current ratio
4.2
Quick ratio
2.74
Net debt/EBITDA
2.56
Margins
Efficiency
Dividend
EBITDA margin
32.5%
Gross margin
55.8%
Net margin
18.9%
Operating margin
29.6%
Return on assets
6.4%
Return on equity
12.2%
Return on invested capital
23.8%
Return on capital employed
10.1%
Return on sales
29.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PBH stock price
How has the Prestige Consumer Healthcare stock price performed over time
Intraday
-0.09%
1 week
0.52%
1 month
0.71%
1 year
31.97%
YTD
8.58%
QTD
-1.37%
Financial performance
How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.14B
Gross profit
$634.46M
Operating income
$336.78M
Net income
$214.61M
Gross margin
55.8%
Net margin
18.9%
Prestige Consumer Healthcare's gross profit has increased by 3% QoQ
The net income has grown by 2.5% YoY
PBH's operating margin is down by 2.6% year-on-year
Price vs fundamentals
How does PBH's price correlate with its fundamentals
Growth
What is Prestige Consumer Healthcare's growth rate over time
Valuation
What is Prestige Consumer Healthcare stock price valuation
P/E
19.63
P/B
2.29
P/S
3.7
EV/EBIT
15.48
EV/EBITDA
13.91
EV/Sales
4.51
PBH's P/E is 32% above its 5-year quarterly average of 14.9 and 9% above its last 4 quarters average of 18.0
The EPS has grown by 2.6% YoY
PBH's price to book (P/B) is 21% higher than its 5-year quarterly average of 1.9 and 9% higher than its last 4 quarters average of 2.1
The equity has grown by 11% YoY and by 2.6% from the previous quarter
The price to sales (P/S) is 37% higher than the 5-year quarterly average of 2.7 and 9% higher than the last 4 quarters average of 3.4
Efficiency
How efficient is Prestige Consumer Healthcare business performance
PBH's ROE is down by 9% YoY and by 2.4% QoQ
Prestige Consumer Healthcare's ROIC has increased by 6% YoY
The ROS has contracted by 4.3% YoY
Dividends
What is PBH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 117% higher than its total liabilities
The quick ratio has increased by 43% YoY and by 29% from the previous quarter
The current ratio is up by 31% year-on-year and by 14% since the previous quarter
The company's debt is 43% lower than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 17% YoY
The equity has grown by 11% YoY and by 2.6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.